Brain Tumor Treatment
Brain Tumor Treatment - Related Videos
03:10
Treatment of Brain Tumors in a Mouse Model Using Sonodynamic Therapy
0 Views •
2025
Source: Mess, G., et al. Sonodynamic Therapy for the Treatment of Glioblastoma Multiforme in a Mouse Model Using a Portable Benchtop Focused Ultrasound System. J. Vis. Exp. (2023)This video demonstrates a protocol for performing sonodynamic therapy on a brain tumor in a mouse model using magnetic resonance-guided focused ultrasound (MRgFUS). A sonosensitizer precursor is administered prior to treatment, which accumulates in tumor cells and is activated by focused ultrasound to produce reactive...
07:16
Thermal Ablation for the Treatment of Abdominal Tumors
0 Views •
Cited by 19 •
2011
A thermal tumor ablation procedure is described. The entire procedure is detailed, including pretreatment planning and imaging studies, anesthesia, adjuvant techniques to facilitate a percutaneous approach, imaging guidance of the ablation device to the tumor, thermal treatment, post-treatment care and follow-up.
04:15
Brain Tumor Stem Cell (BTSC) Migration Assay for Drug Treatment Studies: An In Vitro Live-cell Imaging Technique to Analyze the Effect of Drug Treatment on Migration of BTSCs
0 Views •
2025
In this video, we perform brain tumor stem cell migration assay to analyze the effect of the drug of interest on the migration of live brain tumor stem cells using chemotaxis migration plate. Live-cell imaging facilitates the visualization and quantification of cell migration during the assay.
10:13
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
0 Views •
Cited by 29 •
2015
Many types of human brain tumors are localized to specific regions within the brain and are difficult to grow in culture. This protocol addresses the role of tumor microenvironment and investigates new drug treatments by analyzing fluorescent primary brain tumor cells growing in an organotypic mouse brain slice.
08:02
Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
0 Views •
Cited by 9 •
2012
The purpose of this article is to describe the use of an orthotopic glioblastoma model for chemoradiation studies. This article will go though cell processing, implanting, and radiotherapy of the mouse using an intracranial model.
FAQs
Transport across the blood-brain barrier is difficult because therapies intended for a brain tumor must reach abnormal tissue without exposing the rest of the body to unnecessary drug. Bioengineering addresses this challenge by developing delivery systems that improve passage into the brain. The goal is to make treatment more precise while reducing systemic toxicity, especially when conventional delivery is limited.
These characteristics help determine which interventions can be considered and how they should be coordinated. Location matters because therapy must reach the tumor while preserving nearby neurological function, whereas molecular features can help distinguish tumors that may require different therapeutic strategies. Patient health adds another constraint, so treatment planning balances tumor control with the individual’s ability to tolerate care.
Engineered biomaterials can support localized therapy in the tumor region, helping focus treatment where it is needed rather than relying only on distribution throughout the body. This approach is intended to increase therapeutic precision and reduce systemic toxicity. In bioengineering research, biomaterials connect the physical delivery environment with the clinical goal of protecting healthy tissue during treatment.
Laboratory models provide a setting for examining how a tumor may respond to a proposed treatment during development. In the bioengineering context, these models are used to predict treatment responses and support investigation of treatment resistance. Their value lies in providing information that can guide more informed and potentially personalized strategies for tumors with differing biological behavior.
Bioengineered drug-delivery systems and localized biomaterials offer complementary ways to address limited access. Delivery systems are designed to improve transport across the blood-brain barrier, while biomaterials support therapy concentrated at a relevant site. Together, these approaches aim to increase precision and reduce systemic exposure, making them particularly relevant when conventional treatment cannot adequately reach the tumor.
Bioengineering does not replace surgery, radiation therapy, chemotherapy, targeted drugs, or immunotherapy; instead, it can improve how selected treatments are delivered and evaluated. Its contributions include more precise delivery, lower systemic toxicity, laboratory-based prediction of response, and support for personalized strategies. These benefits are especially relevant when tumors are hard to reach or resistant to conventional treatment.